Cargando…
Profile of deferasirox for the treatment of patients with non-transfusion-dependent thalassemia syndromes
It has been clearly shown that iron overload adds progressively significant morbidity and mortality in patients with non-transfusion-dependent thalassemia (NTDT). The lack of physiological mechanisms to eliminate the excess of iron requires effective iron chelation therapy. The reduced compliance to...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4687615/ https://www.ncbi.nlm.nih.gov/pubmed/26719673 http://dx.doi.org/10.2147/DDDT.S40694 |